The leishmaniasis model

Methods in Microbiology

Volumn 32, Issue , 2002, Pages 463-492

  Kropf, Pascale ^a   Müller, Ingrid ^a   Brunson, Kevin ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b WA State Caseload Forecast Council   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34548717241     PISSN: 05809517     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0580-9517(02)32102-0     Document Type: Review

References (52)

1. A.M Beebe S Mauze N.J Schork R.L Coffman Serial backcross mapping of multiple loci associated with resistance to Leishmania major in mice Immunity 6 1997 551 557
2. M Belosevic D.S Finbloom P.H van der Meide M.V Slayter C.A Nacy Administration of monoclonal anti-IFN-γ antibodies in vivo abrogates resistance of C3H/HeN mice to infection with Leishmania major J. Immuno1. 143 1989 266 274
3. P.A Bretscher G Wei J.N Menon H Bielefeldt-Ohmann Establishment of stable, cell-mediated immunity that makes “susceptible” mice resistant to Leishmania major Science 257 1992 539 542
4. E.M Carvalho M Barral-Neto A Barral C.I Broskyn O Bacellar Immunoregulation in leishmaniasis Ciência e Cultura (Journal of the Brazilian Association for the Advancement of Science) 46 1994 441 445
5. R Chatelain K Varkila R.L Coffman IL-4 induces a Th2 response in Leishmania major -infected mice J. Immunol. 148 1992 1182 1187
6. R DaSilva D.L Sacks Metacyclogenesis is a major determinant of Leishmania promastigote virulence and attenuation Infect. Immun. 55 1987 2802 2806
7. L.J De Tolla P.A Scott J.P Farrell Single gene control of resistance to cutaneous leishmaniasis in mice Immunogenetics 14 1981 29 39
8. D.P Dialynas Z.S Quan K.A Wall A Pierres J Quintans M.R Loken M Pierres F.W Fitch Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: Similarity of L3T4 to the human Leu3/T4 molecule J. Immunol. 131 1983 2445 2451
9. A.H Ding C.F Nathan D.J Stuehr Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production J. Immunol. 141 1988 2407 2412
10. B Etges I Müller Progressive disease or protective immunity to Leishmania major infection: the result of a network of stimulatory and inhibitory interactions J. Mol. Med. 76 1998 372 390
11. J.P Farrell I Müller J.A Louis A role for Lyt2+ T cells in resistance to cutaneous leishmaniasis in immunized mice J. Immunol. 142 1989 2052 2056
12. M.A Freudenberg D Keppler C Galanos Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin Infect. Immun. 59 1986 891 895
13. F.P Heinzel R.M Rerko F Ahmed E Pearlman Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice J. Immunol. 155 1995 730 739
14. J.O Hill R.J North F.M Collins Advantages of measuring changes in the number of viable parasites in murine models of experimental cutaneous leishmaniasis Infect. Immun. 39 1983 1087 1094
15. J.C Howard G Hale F.Y Liew Immunological regulation of experimental cutaneous leishmaniasis. IV. Prophylactic effect of sublethal irradiation as a result of abrogation of suppressor T cell generation in mice genetically susceptible to Leishmania tropica J. Exp. Med. 153 1981 557 568
16. + T cells through IL-12 produced by Listeria -induced macrophages Science 260 1993 547 549
17. A.F Kiderlen P.M Kaye A modified colorimetric assay of macrophage activation for intracellular cytotoxicity against Leishmania parasites J. Immunol. Methods 127 1990 11 18
18. P Kropf R Etges L Schopf C Chung J Sypek I Müller Characterization of T cell-mediated responses in non-healing and healing Leishmania major infections in the absence of endogenous interleukin-4 J. Immunol. 159 1997 3434 3443
19. P Kropf L.R Schopf C.L Chung D Xu F.Y Lieu J.P Sypek I Müller Expression of Th2 cytokines and the stable Th2 marker ST2L in the absence of IL-4 during Leishmania major infection Eur. J. Immunol. 29 1999 3621 3628
20. P Launois I Maillard S Pingel K.G Swihart L Xenarios H Acha-Orbea H Diggelmann R.M Locksley R MacDonald J.A Louis IL-4 rapidly produced by Vβ4Vα8 CD4` T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice Immunity 6 1997 541 549
21. O Leo M Foo D.H Sachs L.E Samelson J.A Bluestone Identification of a monoclonal antibody specific for a murine T3 polypeptide Proc. Natl. Acad. Sci. USA 84 1987 1374 1378
22. F.Y Liew C.A O'Donnell Immunology of Leishmaniasis Adv. Parasitol. 32 1993 162 259
23. F Mattner J Magram J Ferrante P Launois K Di Padova R Behin M.K Gately J.A Louis G Alber Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response Eur. J. Immunol. 26 1996 1553 1559
24. J Mauel S Betz-Corradin Y Buchmüller Rouiller Nitrogen and oxygen metabolites and the killing of Leishmania by activated murine macrophages Res. Immunol. 142 1991 577 580
25. J.N Menon P.A Bretscher Characterization of the immunological state generated in mice susceptible to Leishmania major following exposure to low doses of L. major and resulting in resistance to a normally pathogenic challenge Eur. J. Immunol. 26 1996 243 249
26. F Modabber Vaccine: The only hope to control leishmaniasis F.J Tapia G Caceres-Dittmar M.A Sanchez Molecular and Immune Mechanisms in the Pathogenesis of Cutaneous Leishmaniasis 1996 R.G. Landes Company Texas, USA 222 236
27. T Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 65 1983 55 63
28. + T cells that promote parasite growth distinct from those mediating resistance? Immunol. Lett. 19 1988 251 260
29. + T cells Int. Immunol. 3 1991 587 597
30. G.S Nabors J.P Farrell Site-specific immunity to Leishmania major in SWR mice: the site of infection influences susceptibility and expression of the antileishmanial immune response Infect. Immun. 62 1994 3655 3662
31. G.S Nabors L.C.C Afonso J.P Farrell P Scott Switch from a type 2 to a type 1 T helper cell response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin 12 and pentostam Proc. Natl. Acad. Sci. 92 1995 3142 3146
32. N Noben-Trauth P Kropf I Müller Susceptibility to Leishmania major infection in interleukin-4 deficient mice Science 271 1996 987 990
33. N Noben-Trauth W.E Paul D.L Sacks IL-4 and IL-4 receptordeficient BALB/c mice reveal differences in susceptibility to Leishmania major parasite substrains J. Immunol. 162 1999 6132 6140
34. J Ohara W.E Paul Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1 Nature 315 1985 333 336
35. I.P Oswald T.A Wynn A Sher S.L James NO as an effector molecule of parasite killing: modulation of its synthesis by cytokines Comp. Biochem. Physiol. 108C 1994 11 18
36. C.D.P PAHO Leishmaniasis in the Americas Epidem. Bull1PAHO 15 3 1994 8 13
37. P.M Preston D.C Dumonde Experimental cutaneous leishmaniasis. V. Protective immunity in subclinical and self-healing infection in the mouse Clin. Exp. Immunol. 23 1976 126 138
38. S.L Reiner R.M Locksley The regulation of immunity to Leishmania major Annu. Rev. Immunol. 13 1995 151 177
39. D.L Sacks R.P Da Silva The generation of infective stage Leshmania major promastigotes is associated with the cell-surface expression and release of a developmentally regulated glycolipid J. Immunol. 139 1987 3099 3106
40. D.L Sacks P.V Perkins Identification of an infective stage of Leishmania promastigotes Science 223 1984 1417 1419
41. D.L Sacks S Hieny A Sher Identification of cell surface carbohydrate and antigenic changes between noninfective and infective developmental stages of Leishmania major promastigotes J. Immunol. 135 1985 564 569
42. M.D Sadick F.P Heinzel B.J Holaday R.T Pu R.S Dawkins R.M Locksley Cure of murine leishmaniasis with anti-interleukin-4 monoclonal antibody. Evidence for a T-cell-dependent, interferon-y-independent mechanism J. Exp. Med. 171 1990 115 127
43. P.A Scott J.P Farrell Experimental cutaneous leishmaniasis: disseminated leishmaniasis in genetically susceptible and resistant mice Am. J. Trop. Med. Hyg. 31 1982 230 238
44. J.P Sypek C.L Chung S.E.H Mayor J.M Subramanyam S.J Goldman D.S Sieburth S.F Wolf R.G Schaub Resolution of cutaneous leishmaniasis: Interleukin 12 initiates a protective T helper type 1 immune response J. Exp. Med. 177 1993 1797 1802
45. C Taswell Limiting dilution assays for the separation, characterization, and quantitation of biologically active particles and their clonal progeny T.G Pretlow T.P Pretlow Cell Separation: Methods and Selected Applications Vol. 4 1987 Academic Press London 109 145
46. R.G Titus R Ceredig J.C Cerottini J.A Louis Therapeutic effect of anti-L3T4 monoclonal antibody GKl.5 on cutaneous leishmaniasis in genetically susceptible BALB/c mice J. Immunol. 135 1985 2108 2114
47. R.G Titus M Marchand T Boon J.A Louis A limiting dilution assay for quantifying Leishmania major in tissues of infected mice Parasite Immunol. 7 1985 545 555
48. S Turco A Descoteaux The lipophosphoglycan of Leishmania parasites Annn. Rev. Microbiol. 46 1992 65 94
49. M Ulrich V Rodriguez M Centeno The Immoral response in leishmaniasis F.J Tapia G Caceres-Dittmar M.A Sanchez Molecular and Immune Mechanisms in the Pathogenesis of Cutaneons Leishmaniasis 1996 R.G. Landes Company Austin, Texas 189 202
50. L.Q Vieira M Goldschmidt M Nashleanas K Pfeffer T Mak P Scott Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major , but control parasite replication J. Immunol. 157 1996 827 835
51. X Wei I.G Charles A Smith J Ure G Feng F Huang D Xu W Müller S Moncada F.Y Liew Altered immune responses in mice lacking inducible nitric oxide synthase Nature 375 1995 408 411
52. World Health Organization Leishmaniasis Tropical Disease Research. 20 Years of Progress 1995 World Health Organization 135 146 Geneva